Skip to main content

FibroBiologics, Inc.

corporate_fare Company Profile

FibroBiologics, Inc.

FibroBiologics, Inc. operates as a cell therapy, regenerative medicine company. It is developing a pipeline of treatments and potential cures for chronic diseases, including wound healing, multiple sclerosis, degenerative disc disease, psoriasis, certain cancers, and potential human longevity applications. The company was founded in 2021 and is based in Houston, Texas.

Exchange: NASDAQSector: Life Sciences

show_chartPrice Chart

Loading chart...

feed FBLG - Latest Insights

FBLG
Apr 22, 2026, 4:34 PM EDT
Filing Type: PRE 14A
Importance Score:
9
Stockholders to Vote on Highly Dilutive Warrant Issuance and New Equity Plan
Sentiment: Negative
View Wiseek Article
FBLG
Apr 20, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
8
FibroBiologics Confirms Full Nasdaq Compliance, Resolving Delisting Risk
Sentiment: Positive
View Wiseek Article
FBLG
Apr 10, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
FibroBiologics Unveils Novel Thymus Organoid Platform Showing Preclinical Potential in Immune Decline, Cancer
Sentiment: Positive
View Wiseek Article
FBLG
Apr 09, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
8
FibroBiologics Terminates Sublease, Expects $0.8M in Savings
Sentiment: Positive
View Wiseek Article
FBLG
Apr 03, 2026, 4:02 PM EDT
Filing Type: 8-K
Importance Score:
7
FibroBiologics Implements 1-for-20 Reverse Stock Split to Address Nasdaq Compliance
Sentiment: Negative
View Wiseek Article
FBLG
Apr 02, 2026, 5:41 PM EDT
Source: Reuters
Importance Score:
7
FibroBiologics Closes $3M Public Offering, Securing Critical Capital
Sentiment: Neutral
View Wiseek Article
FBLG
Apr 02, 2026, 4:03 PM EDT
Filing Type: 8-K
Importance Score:
7
FibroBiologics Finalizes $2.5M Public Offering, Securing Critical Capital
Sentiment: Neutral
View Wiseek Article
FBLG
Apr 01, 2026, 4:19 PM EDT
Filing Type: 424B4
Importance Score:
9
FibroBiologics Finalizes $3.0M Public Offering at Deep Discount, Resulting in Over 64% Immediate Dilution
Sentiment: Negative
View Wiseek Article
FBLG
Mar 31, 2026, 8:01 PM EDT
Source: Dow Jones Newswires
Importance Score:
9
FibroBiologics Prices 2.3M Share and Warrant Offering at $1.32, Raising Over $3 Million
Sentiment: Negative
View Wiseek Article
FBLG
Mar 31, 2026, 4:15 PM EDT
Source: GlobeNewswire
Importance Score:
7
FibroBiologics Successfully Manufactures CYWC628 Drug Product, Paving Way for Diabetic Foot Ulcer Clinical Trial
Sentiment: Positive
View Wiseek Article
FBLG
Mar 27, 2026, 5:19 PM EDT
Filing Type: S-1
Importance Score:
8
FibroBiologics Files S-1 for Up to $10.4M Offering Amid Nasdaq Compliance Issues and Going Concern Warning
Sentiment: Negative
View Wiseek Article
FBLG
Mar 25, 2026, 4:31 PM EDT
Source: Reuters
Importance Score:
8
FibroBiologics to Execute 1-for-20 Reverse Stock Split to Meet Nasdaq Bid Price
Sentiment: Negative
View Wiseek Article
FBLG
Mar 13, 2026, 4:20 PM EDT
Filing Type: 10-K/A
Importance Score:
8
FibroBiologics Amends 10-K to Disclose Significant Dilutive Financing and Executive Compensation Details
Sentiment: Negative
View Wiseek Article
FBLG
Mar 12, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
FibroBiologics' Fibroblast Technology Shows Promise in Burn Treatment, Targets $2.55B Market
Sentiment: Positive
View Wiseek Article
FBLG
Mar 03, 2026, 8:00 AM EST
Filing Type: 4
Importance Score:
7
CFO Buys $28,973 in Open Market Shares Amidst Company Challenges
Sentiment: Positive
View Wiseek Article
FBLG
Mar 02, 2026, 8:41 AM EST
Source: Reuters
Importance Score:
7
FibroBiologics Secures U.S. Patent for Osteoporosis Cell Therapy
Sentiment: Positive
View Wiseek Article
FBLG
Feb 24, 2026, 4:06 PM EST
Filing Type: 10-K
Importance Score:
8
FibroBiologics Reports Going Concern Doubt, Nasdaq Delisting Risk, and Material Weakness in Annual Filing
Sentiment: Negative
View Wiseek Article
FBLG
Feb 23, 2026, 4:18 PM EST
Filing Type: 8-K
Importance Score:
9
Shareholders Approve Reverse Stock Split and Significant Warrant Share Issuances to Address Nasdaq Compliance
Sentiment: Negative
View Wiseek Article
FBLG
Feb 06, 2026, 4:10 PM EST
Filing Type: 8-K
Importance Score:
9
FibroBiologics Faces Second Nasdaq Delisting Threat for Market Value Deficiency
Sentiment: Negative
View Wiseek Article
FBLG
Jan 02, 2026, 5:16 PM EST
Filing Type: 8-K
Importance Score:
9
FibroBiologics Receives Nasdaq Delisting Notice; Plans Appeal and Reverse Stock Split
Sentiment: Negative
View Wiseek Article